Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending December 27, 2020 MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole, Transcranial direct current stimulation not clinically relevant in MDD, Interleukin-1 β and TNF-α hamper antidepressant response in MDD, Impact of pimavanserin on anxious depression in patients with MDD, Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms, More must reads Must reads for theWeek ending December 20, 2020 COVID-19 vaccine found effective but doctors watching for reactions, adverse events, Study links sleep meds and dementia risk in older adults, E-cigarette use tied to increased COPD, asthma risk, More must readsMust reads for theWeek ending December 13, 2020 Prescription opioid use tied to increased risk for MDD, anxiety, Pain negatively correlates with functionality in patients with partially remitted MDD, Psilocybin-assisted therapy is effective in patients with MDD, Adjunctive minocycline holds potential for treatment of MDD, Cognitive deficits in MDD linked to lifestyle and health-related factors, More must readsMust reads for theWeek ending December 6, 2020 Obesity, hypoxia predict severity in children with COVID-19, More must readsMust reads for theWeek ending November 29, 2020 Antidepressant use partially mediates the link between MDD and risk for falls, Anger attacks may be associated with elevated suicidal ideation in patients with MDD, PHQ-9 is a reliable tool to screen for MDD and assess its severity, MDD: Serum uric acid levels may influence suicide risk in female patients, MDD tied to increased risk for psoriasis, More must readsPages1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »
